[1]李 鼎,王 鼎,刘浩峰,等.深度分析胃癌手术中淋巴结清扫方式对远期效果的影响[J].医学信息,2024,37(17):59-63.[doi:10.3969/j.issn.1006-1959.2024.17.010]
　LI Ding,WANG Ding,LIU Hao-feng,et al.In-depth Analysis of the Effect of Lymph Node Dissection on Long-term Results in Gastric Cancer Surgery[J].Journal of Medical Information,2024,37(17):59-63.[doi:10.3969/j.issn.1006-1959.2024.17.010]
点击复制

深度分析胃癌手术中淋巴结清扫方式对远期效果的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年17期
页码:
59-63
栏目:
论著
出版日期:
2024-09-01

文章信息/Info

Title:
In-depth Analysis of the Effect of Lymph Node Dissection on Long-term Results in Gastric Cancer Surgery
文章编号:
1006-1959（2024）17-0059-05
作者:
李 鼎; 王 鼎; 刘浩峰; 江晓晖
南通大学附属肿瘤医院/南通市肿瘤医院胃肠外科，江苏 南通 226361
Author(s):
LI Ding; WANG Ding; LIU Hao-feng; JIANG Xiao-hui
Department of Gastrointestinal Surgery,Tumor Hospital Affiliated to Nantong University/Nantong Tumor Hospital,Nantong 226361,Jiangsu,China
关键词:
D2+8p淋巴结清扫; 可切除进展期胃癌; 生存分析
Keywords:
D2+8p lymph node dissection; Resectable advanced gastric cancer; Survival analysis
分类号:
R735.2
DOI:
10.3969/j.issn.1006-1959.2024.17.010
文献标志码:
A
摘要:
目的 研究可切除进展期胃癌进行D2+No.8p淋巴结清扫对比单纯D2淋巴结清扫的优势价值。方法 选取2017年1月-2019年1月就诊于我院的可切除进展期胃癌130例，其中D2+8p组70例，D2组60例。对比两组一般临床资料、术中相关资料、术后病理资料，评估两组资料选择的一致性，然后对两组治疗的生存数据进行统计，分析D2+8p淋巴结清扫对于可切除进展期胃癌的远期优势。结果 两组术前资料比较显示，患者年龄、性别、肿瘤位置、肿瘤大小、术前肿瘤标志物CEA、CA724、CA199比较，差异无统计学意义（P＞0.05）；D2+8p组的手术时间长于D2组（P＜0.05），但两者住院时间比较，差异无统计学意义（P＞0.05）。两组患者术后病理学资料中T分期、N分期、AJCC分期、组织学分化程度、Lauren分型比较，差异无统计学意义（P＞0.05）；D2+8p组的淋巴结检出数量和阳性淋巴结数量都多于D2组（P＜0.05）；经过3年6个月随访，D2+8p组生存时间长于D2组（P＜0.05）。结论 D2+8p清扫对于可切除进展期胃癌的远期生存具有明显价值。
Abstract:
Objective To study the value of D2+No.8p lymph node dissection in resectable advanced gastric cancer that compared with D2 lymph node dissection alone.Methods A total of 130 cases of resectable advanced gastric cancer treated in our hospital from January 2017 to January 2019 were selected, including 70 cases in the D2+8p group and 60 cases in the D2 group. The general clinical data, intraoperative related data and postoperative pathological data of the two groups were compared to evaluate the consistency of data selection between the two groups. Then the survival data of the two groups were statistically analyzed to analyze the long-term advantages of D2+8p lymph node dissection for resectable advanced gastric cancer.Results The comparison of preoperative data between the two groups showed that there were no significant difference in age, gender, tumor location, tumor size, preoperative tumor markers CEA, CA724 and CA199 between the two groups (P>0.05). The operation time of the D2+8p group was longer than that of the D2 group (P<0.05), but there was no significant difference in hospitalization time between the two groups (P>0.05). There were no significant difference in T stage, N stage, AJCC stage, histological differentiation and Lauren classification between the two groups (P>0.05). The number of lymph nodes detected and the number of positive lymph nodes in the D2+8p group were more than those in the D2 group (P<0.05). After 3 years and 6 months of follow-up, the survival time of the D2+8p group was longer than that of the D2 group (P<0.05).Conclusion D2+8p dissection has significant value for the long-term survival of resectable advanced gastric cancer.

参考文献/References:

[1]Sung H,Ferlay J,Siegel RL,et al.Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J].CA Cancer J Clin,2021,71(3):209-249.[2]Fdrlay J,Colombet M,Soerjomataram I,et al.Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods[J].Int J Cancer,2019,144(8):1941-1953.[3]Brayf F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.[4]Xia C,Dong X,Li H,et al.Cancer statistics in China and United States, 2022: profiles, trends, and determinants[J].Chin Med J (Engl),2022,135(5):584-590.[5]Cao W,Chen HD,Yu YW,et al.Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020[J].Chin Med J (Engl),2021,134(7):783-791.[6]孙晓琨.近四十年来我国消化系统癌症的发病状况及其危险因素研究[D].遵义:遵义医科大学,2021.[7]刘正新.胃镜下胃癌的早期诊断和治疗[J].国际消化病杂志,2008(1):3-5.[8]Ajani JA,D’Amico TA,Bentrem DJ,et al.Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology[J].J Natl Compr Canc Netw,2022,20(2):167-192.[9]陈峻青.日本胃癌处理规约第13版重要修改内容简介[J].中国实用外科杂志,2000,20(1):60-62.[10]胡祥.第14版日本《胃癌处理规约》的重要变更[J].中国实用外科杂志,2010,30(4):241-246.[11]Hartgrink HH,van de Velde CJ,Putter H,et al.Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial[J].J Clin Oncol,2004,22(11):2069-2077.[12]Cuschieri A,Fayers P,Fielding J,et al.Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group[J].Lancet,1996,347(9007):995-999.[13]Mcculloch P,Nita ME,Kazi H,et al.Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach[J].Cochrane Database Syst Rev,2004(4):D1964.[14]Songun I,Putter H,Kranenbarg EM,et al.Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial[J].Lancet Oncol,2010,11(5):439-449.[15]Monrabal LM,Murdoch DNS,Bertona S,et al.Current standards of lymphadenectomy in gastric cancer[J].Updates Surg,2023,75(7):1751-1758.[16]Smyth EC,Nilsson M,Grabsch HI,et al.Gastric cancer[J].Lancet,2020,396(10251):635-648.[17]Li JQ,He D,Liang YX.Current status of extended ’D2 plus’ lymphadenectomy in advanced gastric cancer[J].Oncol Lett,2021,21(6):467.[18]Meng X,Wang L,Liu G,et al.D2 lymphadenectomy with complete mesogastrium excision vs. conventional D2 gastrectomy for advanced gastric cancer[J].Chin Med J (Engl),2022,135(10):1223-1230.[19]Chiarello M M,Fico V,Pepe G,et al.Early gastric cancer: A challenge in Western countries[J].World J Gastroenterol, 2022,28(7): 693-703.[20]Bechtolsheim F,Distler M,Weitz J,et al.[Robot-Assisted Minimally Invasive D2 Lymphadenectomy][J].Zentralbl Chir,2021,146(2):159-162.[21]Zeng Y,Wei S,Chen S,et al.The Influence of Group No.8p Lymph Node Dissection on the Prognosis of Advanced Gastric Cancer[J].J Gastrointest Surg,2023,27(5):887-894.[22]Varga Z,Kolozsi P,Nagy K,et al.Optimal extent of lymph node dissection in gastric cancer[J].Front Surg,2022,9(7):1093324.

更新日期/Last Update: 1900-01-01